Page 80 - GTM-2-3

Global Translational Medicine Thromboembolism risk in non-small-cell lung cancer

Conflict of interest 6. White RH, Zhou H, Romanos PS, 2003, Incidence of
symptomatic venous thromboembolism after different elective
All authors declare that they have no conflicts of interest. or urgent surgical procedures. Thromb Haemost, 90: 446–455.
Author contributions https://doi.org/10.1160/TH03-03-0152

Conceptualization: All authors 7. Swiniarska J, Zekanowska E, Dancewicz M, et al., 2009,
Investigation: All authors Pneumonectomy due to lung cancer results in a more
Writing – original draft: Suna Kavurgacı pronounced activation of coagulation system than
lobectomy. Eur J Cardiothorac Surg, 36: 1064–1068.
Writing – review & editing: Suna Kavurgacı, Yasemin
Söyler, Ülkü Yılmaz https://doi.org/10.1016/j.ejcts.2009.04.070
8. Yu J, Li A, Laureano M, et al., 2019, Frequency of arterial
Ethics approval and consent to participate thromboembolism in populations with malignancies:

The study was approved by the Ethics Committee of A systematic review. Thromb Res, 184: 16–23.
Ankara Atatürk Sanatorium Education and Training https://doi.org/10.1016/j.thromres.2019.10.004
Hospital with the number 10.10.2022/37, performed in 9. Guan JL, Zhong WZ, An SJ, et al., 2013, KRAS mutation in
accordance with the Good Clinical Practice guidelines and patients with lung cancer: A predictor for poor prognosis
assent specific to our country. The Declaration of Helsinki but not for EGFR-TKIs or chemotherapy. Ann Surg Oncol,
and its subsequent revisions were followed. 20: 1381–1388.

Consent for publication https://doi.org/10.1245/s10434-012-2754-z
This study was of a retrospective nature, and an informed 10. Corrales-Rodriguez L, Soulières D, Weng X, et al., 2014,
consent form was waived. Mutations in NSCLC and their link with lung cancer-
associated thrombosis: A case-control study. Thromb Res,
Availability of data 133: 48–51.
The dataset generated during and/or analyzed during the https://doi.org/10.1016/j.thromres.2013.10.042
current study is available from the corresponding author 11. Verso M, Chiari R, Mosca S, et al., 2015, Incidence of Ct scan-
on reasonable request. detected pulmonary embolism in patients with oncogene-
addicted, advanced lung adenocarcinoma. Thromb Res,
References 136: 924–927.
1. Shinagare AB, Okajima Y, Oxnard GR, et al., 2012, https://doi.org/10.1016/j.thromres.2015.09.006
Unsuspected pulmonary embolism in lung cancer patients:
Comparison of clinical characteristics and outcome with 12. Zer A, Moskovitz M, Hwang DM, et al., 2017, ALK-
suspected pulmonary embolism. Lung Cancer, 78: 161–166. rearranged non-small-cell lung cancer is associated with a
high rate of venous thromboembolism. Clin Lung Cancer,
https://doi.org/10.1016/j.lungcan.2012.08.007 18: 156–161.
2. Lee AY, 2005, Management of thrombosis in cancer: Primary https://doi.org/10.1016/j.cllc.2016.10.007
prevention and secondary prophylaxis. Br J Haematol,
128: 291–302. 13. Dou F, Zhang Y, Yi J, et al., 2020, Association of ALK
rearrangement and risk of venous thromboembolism in
https://doi.org/10.1111/j.1365-2141.2004.05292.x patients with non-small cell lung cancer: A prospective
3. Blom JW, Doggen CJ, Osanto S, et al., 2005, Malignancies, cohort study. Thromb Res, 186: 36–41.
prothrombotic mutations, and the risk of venous thrombosis. https://doi.org/10.1016/j.thromres.2019.12.009
JAMA, 293: 715–722.
14. Khorana AA, Vadhan-Raj S, Kuderer NM, et al., 2017,
https://doi.org/10.1001/jama.293.6.715 Rivaroxaban for preventing venous thromboembolism in
4. Timp JF, Braekkan SK, Versteeg HH, et al., 2013, high-risk ambulatory patients with cancer: Rationale and
Epidemiology of cancer-associated venous thrombosis. design of the CASSINI trial. Rationale and design of the
Blood, 122: 1712–1723. CASSINI trial. Thromb Haemost, 117: 2135–2145.
https://doi.org/10.1182/blood-2013-04-460121 https://doi.org/10.1160/TH17-03-0171
5. Clagett GP, Reisch JS, 1988, Prevention of venous 15. Carrier M, Abou-Nassar K, Mallick R, et al., 2019, Apixaban
thromboembolism in general surgical patients. Results of to prevent venous thromboembolism in patients with
meta-analysis. Ann Surg, 208: 227–240. cancer. N Engl J Med, 380: 711–719.
https://doi.org/10.1097/00000658-198808000-00016 https://doi.org/10.1056/NEJMoa1814468

Volume 2 Issue 3 (2023) 7 https://doi.org/10.36922/gtm.1027